ATE334147T1 - Agonisten des corticotropin-freisetzenden faktor rezeptors 2 - Google Patents

Agonisten des corticotropin-freisetzenden faktor rezeptors 2

Info

Publication number
ATE334147T1
ATE334147T1 AT03703867T AT03703867T ATE334147T1 AT E334147 T1 ATE334147 T1 AT E334147T1 AT 03703867 T AT03703867 T AT 03703867T AT 03703867 T AT03703867 T AT 03703867T AT E334147 T1 ATE334147 T1 AT E334147T1
Authority
AT
Austria
Prior art keywords
agonists
factor receptor
releasing factor
corticotropin releasing
corticotropin
Prior art date
Application number
AT03703867T
Other languages
English (en)
Inventor
Robert Joseph Isfort
Wieslaw Adam Mazur
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE334147T1 publication Critical patent/ATE334147T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57509Corticotropin releasing factor [CRF] (Urotensin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03703867T 2002-01-16 2003-01-16 Agonisten des corticotropin-freisetzenden faktor rezeptors 2 ATE334147T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34911702P 2002-01-16 2002-01-16
US37633702P 2002-04-29 2002-04-29
US38889502P 2002-06-14 2002-06-14
US41198802P 2002-09-19 2002-09-19

Publications (1)

Publication Number Publication Date
ATE334147T1 true ATE334147T1 (de) 2006-08-15

Family

ID=27617822

Family Applications (4)

Application Number Title Priority Date Filing Date
AT06117810T ATE398632T1 (de) 2002-01-16 2003-01-16 Agonisten des corticotropin-freisetzenden faktor rezeptors 2
AT03703867T ATE334147T1 (de) 2002-01-16 2003-01-16 Agonisten des corticotropin-freisetzenden faktor rezeptors 2
AT03731963T ATE383372T1 (de) 2002-01-16 2003-01-16 Agonisten des corticotropin-freisetzenden faktor rezeptors 2
AT03731965T ATE362488T1 (de) 2002-01-16 2003-01-16 Agonisten des corticotropin-freisetzenden faktor rezeptors 2

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06117810T ATE398632T1 (de) 2002-01-16 2003-01-16 Agonisten des corticotropin-freisetzenden faktor rezeptors 2

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT03731963T ATE383372T1 (de) 2002-01-16 2003-01-16 Agonisten des corticotropin-freisetzenden faktor rezeptors 2
AT03731965T ATE362488T1 (de) 2002-01-16 2003-01-16 Agonisten des corticotropin-freisetzenden faktor rezeptors 2

Country Status (30)

Country Link
US (7) US7192923B2 (de)
EP (4) EP1465923B1 (de)
JP (3) JP4489434B2 (de)
KR (3) KR100758857B1 (de)
CN (3) CN100391972C (de)
AR (3) AR038142A1 (de)
AT (4) ATE398632T1 (de)
AU (2) AU2003205197B2 (de)
BR (3) BR0306838A (de)
CA (3) CA2470731C (de)
CY (1) CY1106133T1 (de)
DE (4) DE60321730D1 (de)
DK (2) DK1465921T3 (de)
ES (4) ES2287484T3 (de)
HK (1) HK1078095A1 (de)
IL (5) IL162431A0 (de)
MA (3) MA27590A1 (de)
MX (3) MXPA04006885A (de)
MY (1) MY140306A (de)
NO (3) NO20043371L (de)
NZ (3) NZ533599A (de)
PE (3) PE20030849A1 (de)
PL (3) PL373139A1 (de)
PT (2) PT1465921E (de)
RU (1) RU2294333C2 (de)
SA (3) SA03230564A (de)
SI (1) SI1465921T1 (de)
TW (3) TW200302278A (de)
WO (3) WO2003062277A1 (de)
ZA (1) ZA200404995B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040049009A1 (en) * 2000-09-22 2004-03-11 Klaus Eckart Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US7192923B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
CN101687025A (zh) * 2005-03-30 2010-03-31 诺华疫苗和诊断公司 B型流感嗜血杆菌
US7815905B2 (en) 2006-01-27 2010-10-19 Research Development Foundation Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitors
WO2009043481A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009033692A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of the peptides fibrinopeptide a and pyx-i as a therapeutic agents
WO2009046874A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic combination of trh-potentiating peptide and stresscopin
JP2012508014A (ja) 2008-11-04 2012-04-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Crhr2ペプチド作動薬及びその使用
EP2206726A1 (de) * 2009-01-08 2010-07-14 Universite Joseph Fourier Nichtinvasive Instrumente zum Nachweisen anfälliger atherosklerotischer Plaques
US20110105397A1 (en) * 2009-11-04 2011-05-05 Gengo Peter J Method for treating heart failure with stresscopin-like peptides
WO2013063046A1 (en) 2011-10-24 2013-05-02 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
ES2660492T3 (es) * 2012-02-14 2018-03-22 The Regents Of The University Of California Administración sistémica y expresión regulada de genes paracrinos para enfermedades cardiovasculares y otras afecciones
JOP20170153A1 (ar) * 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
MX2019004401A (es) * 2016-10-20 2019-09-26 Cortene Inc Metodos de tratamiento y enfermedades resultantes de una respuesta de tension mal adaptada.
CN110755434B (zh) * 2018-07-27 2022-03-15 中国医学科学院药物研究所 化合物palosuran防治骨骼肌萎缩等疾病的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
US5786203A (en) 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
EP0860501A3 (de) 1994-06-14 1999-05-19 Neurocrine Biosciences, Inc. Corticotropin freisetzende Rezeptoren des Faktor 2
US5824771A (en) 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US5663292A (en) 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
JP2002504802A (ja) 1995-06-13 2002-02-12 ザ ソルク インスティテュート フォア バイオロジカル スタディース ウロコルチンペプチド
US5869450A (en) 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
JP4873825B2 (ja) 2000-08-04 2012-02-08 リサーチ ディベロップメント ファンデーション ウロコルチン蛋白質及びその利用
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US7192923B2 (en) * 2002-01-16 2007-03-20 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists

Also Published As

Publication number Publication date
AR038143A1 (es) 2004-12-29
CN100475844C (zh) 2009-04-08
BR0306826A (pt) 2005-09-06
IL162431A0 (en) 2005-11-20
NO20043396L (no) 2004-10-06
US20030148956A1 (en) 2003-08-07
DE60321730D1 (de) 2008-07-31
MY140306A (en) 2009-12-31
RU2004124847A (ru) 2005-04-20
NZ533598A (en) 2007-03-30
DE60307044D1 (de) 2006-09-07
MXPA04006883A (es) 2004-12-06
CN1617886A (zh) 2005-05-18
EP1465921B1 (de) 2006-07-26
CA2470656C (en) 2011-06-28
US7462597B2 (en) 2008-12-09
ZA200404995B (en) 2005-06-29
TW200302278A (en) 2003-08-01
ATE383372T1 (de) 2008-01-15
IL196384A0 (en) 2011-07-31
US20100197579A1 (en) 2010-08-05
SA03230564B1 (ar) 2006-10-31
CA2470731C (en) 2011-06-21
MA27592A1 (fr) 2005-11-01
DE60313845T2 (de) 2008-01-31
US7192924B2 (en) 2007-03-20
PE20030974A1 (es) 2003-12-26
PT1465921E (pt) 2006-12-29
KR100758857B1 (ko) 2007-09-14
TW200302277A (en) 2003-08-01
US20030148957A1 (en) 2003-08-07
EP1724283A2 (de) 2006-11-22
IL197774A0 (en) 2009-12-24
JP2005521387A (ja) 2005-07-21
SI1465921T1 (sl) 2006-10-31
US7897731B2 (en) 2011-03-01
CY1106133T1 (el) 2011-06-08
BR0306878A (pt) 2004-10-26
JP4489434B2 (ja) 2010-06-23
KR100758858B1 (ko) 2007-09-14
NZ533600A (en) 2007-02-23
MXPA04006884A (es) 2004-12-06
CA2470656A1 (en) 2003-07-31
ES2269976T3 (es) 2007-04-01
RU2294333C2 (ru) 2007-02-27
TWI300442B (en) 2008-09-01
PL373529A1 (en) 2005-09-05
AR038144A1 (es) 2004-12-29
DK1465921T3 (da) 2006-11-27
SA03230564A (ar) 2005-12-03
US7608701B2 (en) 2009-10-27
DE60318547T2 (de) 2008-12-24
EP1724283B1 (de) 2008-06-18
US20090124793A1 (en) 2009-05-14
AU2003205197B2 (en) 2006-03-02
EP1724283A3 (de) 2007-04-11
SA03230565B1 (ar) 2006-10-31
CN1617887A (zh) 2005-05-18
PL371364A1 (en) 2005-06-13
IL162529A0 (en) 2005-11-20
US20030148958A1 (en) 2003-08-07
WO2003062268A2 (en) 2003-07-31
DE60318547D1 (de) 2008-02-21
US6936585B2 (en) 2005-08-30
DE60313845D1 (de) 2007-06-28
EP1465921A2 (de) 2004-10-13
JP2005522191A (ja) 2005-07-28
TW200302276A (en) 2003-08-01
MA27591A1 (fr) 2005-11-01
JP4508649B2 (ja) 2010-07-21
EP1465922B1 (de) 2008-01-09
US7192923B2 (en) 2007-03-20
MXPA04006885A (es) 2004-12-06
PL373139A1 (en) 2005-08-22
PE20030849A1 (es) 2003-12-01
US20060025339A1 (en) 2006-02-02
ES2287484T3 (es) 2007-12-16
KR20040082390A (ko) 2004-09-24
BR0306838A (pt) 2005-04-05
HK1078095A1 (en) 2006-03-03
JP2005525101A (ja) 2005-08-25
US20080004435A1 (en) 2008-01-03
CN100391972C (zh) 2008-06-04
PT1465923E (pt) 2007-08-06
ES2299701T3 (es) 2008-06-01
WO2003062269A2 (en) 2003-07-31
NO20043371L (no) 2004-10-06
NZ533599A (en) 2007-03-30
AR038142A1 (es) 2004-12-29
PE20030747A1 (es) 2003-10-23
KR100735586B1 (ko) 2007-07-04
CA2470743C (en) 2011-12-13
KR20040082392A (ko) 2004-09-24
ES2309909T3 (es) 2008-12-16
CA2470743A1 (en) 2003-07-31
EP1465923A1 (de) 2004-10-13
KR20040082389A (ko) 2004-09-24
ATE362488T1 (de) 2007-06-15
NO20043366L (no) 2004-10-06
CN1617885A (zh) 2005-05-18
IL162530A0 (en) 2005-11-20
WO2003062277A1 (en) 2003-07-31
WO2003062269A3 (en) 2003-11-06
DK1465923T3 (da) 2007-07-02
US7632933B2 (en) 2009-12-15
DE60307044T2 (de) 2007-02-15
EP1465922A2 (de) 2004-10-13
WO2003062268A3 (en) 2003-11-27
CA2470731A1 (en) 2003-07-31
ATE398632T1 (de) 2008-07-15
JP4508648B2 (ja) 2010-07-21
AU2003237419B2 (en) 2006-04-13
EP1465923B1 (de) 2007-05-16
SA03230565A (ar) 2005-12-03
MA27590A1 (fr) 2005-11-01

Similar Documents

Publication Publication Date Title
IL196384A0 (en) Corticotropin releasing factor 2 receptor agonists
IS7801A (is) Púrín efnasambönd og notkun þeirra sem kannabinóíð viðtaka bindla
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
ATE388937T1 (de) Agonisten des cannabinoidrezeptors
EP1482895A4 (de) Aminoalkylphosphonate und verwandte verbindungen als edg-rezeptoragonisten
EE200200400A (et) Kortikotropiini vabastava faktori antagonistid
GB2389787B (en) Mamalian animal composition
EP1482896A4 (de) Aminoalkylphosphonate und verwandte verbindungen als edg-rezeptor-agonisten
DK1463759T3 (da) Ligand for den G-proteinkoblede receptor GPR43 og anvendelser deraf
FR2835321B1 (fr) Monture d'objectif
DK1487778T3 (da) Substituerede 4 aminocyclohexanoler
SE0203691L (sv) Mataranordning
FI20031042A0 (fi) Puristusmekanismi
DE60303424D1 (de) D-Ring Halterung
ITAN20020022V0 (it) Gancio regolabile per quadri
ZA200404994B (en) Corticotropin releasing factor 2 receptor agonists
SI1465923T1 (sl) Agonisti receptorja 2 faktorja sproščanja kortikotropina
ATE491683T1 (de) Muskarine agonisten
SE0203227D0 (sv) The W/F/T-sens 1/3
FI5368U1 (fi) Syöttölaite
SE0203667L (sv) Matningsanordning
ITIS20020002A1 (it) Termocamino - scorpio idro fair 01
UA6657S (uk) Круглий 89-гранний діамант «аріадна-89»
UA7336S (uk) Монограма «ленінградське»
SE0202438D0 (sv) Anordning 2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1465921

Country of ref document: EP

REN Ceased due to non-payment of the annual fee